published patent: Preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in stroke

TitlePreventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in stroke
Priority Date2006-02-20 JP20060041761
Inventors
Issue Date2009
Citation
China Published Patent Application CN 101389332. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009 How to Cite?
AbstractThe present invention provides a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke such as cerebral infarction and cerebral hemorrhage which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for a long period. The present invention is a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke which contains 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide as an active ingredient. A particularly preferable compound is an optically resolved (2S,4S)-form of fidarestat.
Persistent Identifierhttp://hdl.handle.net/10722/176618

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:15Z-
dc.date.available2012-11-30T08:38:15Z-
dc.date.issued2009-
dc.identifier.citationChina Published Patent Application CN 101389332. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176618-
dc.description.abstractThe present invention provides a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke such as cerebral infarction and cerebral hemorrhage which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for a long period. The present invention is a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke which contains 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide as an active ingredient. A particularly preferable compound is an optically resolved (2S,4S)-form of fidarestat.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titlePreventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in strokeen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorChung, SKen_HK
dc.contributor.inventorChung, Stephenen_HK
dc.contributor.inventorHibi, Chihiroen_HK
patents.identifier.applicationCN 20078006103en_HK
patents.description.assigneeSANWA KAGAKU KENKYUSHO CO [JP]en_HK
patents.description.countryChina, PRCen_HK
patents.date.publication2009-03-18en_HK
patents.date.application2007-02-20en_HK
patents.date.priority2006-02-20 JP20060041761en_HK
patents.description.ccCNen_HK
patents.identifier.publicationCN 101389332en_HK
patents.relation.familyAU 2007218709 (A1) 2007-08-30en_HK
patents.relation.familyCA 2642933 (A1) 2007-08-30en_HK
patents.relation.familyCN 101389332 (A) 2009-03-18en_HK
patents.relation.familyEP 1987829 (A1) 2008-11-05en_HK
patents.relation.familyKR 20080108465 (A) 2008-12-15en_HK
patents.relation.familyUS 2009076105 (A1) 2009-03-19en_HK
patents.relation.familyWO 2007097301 (A1) 2007-08-30en_HK
patents.description.kindAen_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats